Drug Shortage Report for VENCLEXTA

Last updated on 2019-07-31 History
Report ID 84402
Drug Identification Number 02458047
Brand name VENCLEXTA
Common or Proper name Venclexta 50mg unit dose
Company Name ABBVIE CORPORATION
Market Status MARKETED
Active Ingredient(s) VENETOCLAX
Strength(s) 50MG
Dosage form(s) TABLET
Route of administration ORAL
Packaging size 1 tablet blister
ATC code L01XX
ATC description OTHER ANTINEOPLASTIC AGENTS
Reason for shortage Demand increase for the drug.
Anticipated start date 2019-05-14
Actual start date 2019-05-14
Estimated end date 2019-08-08
Actual end date 2019-07-30
Shortage status Resolved
Updated date 2019-07-31
Company comments To ensure continuity of supply across all jurisdictions, and to avoid unnecessary stockpiling, orders will be processed to supply minimal quantity required. This will ensure that we meet patient needs.
Health Canada comments
Tier 3 Status No
Contact Address 8401 TRANS-CANADA HIGHWAY
SAINT-LAURENT, QUEBEC
CANADA H4S 1Z1
Company contact information Should you require any additional information, please contact our Customer Service Department at 1-888-704-8270.

Version History

Click on "Compare" below to view the full report history and compare to other versions.

Version Number Date Updated Language
v1 2019-05-17 English Compare
v2 2019-05-17 French Compare
v3 2019-07-03 English Compare
v4 2019-07-03 French Compare
v5 2019-07-31 English Compare
v6 2019-07-31 French Compare

Showing 1 to 6 of 6